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Abstract
Background: Prompt, accurate diagnosis and treatment with artemisinin combination therapy remains vital to
current malaria control. Blood film microscopy the current standard test for diagnosis of malaria has several
limitations that necessitate field evaluation of alternative diagnostic methods especially in low income countries of
sub-Saharan Africa where malaria is endemic.
Methods: The accuracy of axillary temperature, health centre (HC) microscopy, expert microscopy and a HRP2-
based rapid diagnostic test (Paracheck) was compared in predicting malaria infection using polymerase chain
reaction (PCR) as the gold standard. Three hundred patients with a clinical suspicion of malaria based on fever and
or history of fever from a low and high transmission setting in Uganda were consecutively enrolled and provided
blood samples for all tests. Accuracy of each test was calculated overall with 95% confidence interval and then
adjusted for age-groups and level of transmission intensity using a stratified analysis. The endpoints were:
sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). This study is registered
with Clinicaltrials.gov, NCT00565071.
Results: Of the 300 patients, 88(29.3%) had fever, 56(18.7%) were positive by HC microscopy, 47(15.7%) by expert
microscopy, 110(36.7%) by Paracheck and 89(29.7%) by PCR. The overall sensitivity >90% was only shown by
Paracheck 91.0% [95%CI: 83.1-96.0]. The sensitivity of expert microscopy was 46%, similar to HC microscopy. The
superior sensitivity of Paracheck compared to microscopy was maintained when data was stratified for transmission
intensity and age. The overall specificity rates were: Paracheck 86.3% [95%CI: 80.9-90.6], HC microscopy 93.4% [95%
CI: 89.1-96.3] and expert microscopy 97.2% [95%CI: 93.9-98.9]. The NPV >90% was shown by Paracheck 95.8% [95%
CI: 91.9-98.2]. The overall PPV was <88% for all methods.
Conclusion: The HRP2-based RDT has shown superior sensitivity compared to microscopy in diagnosis of malaria
and may be more suitable for screening of malaria infection.
Background
The World Health Organization (WHO) recommends
prompt parasitological confirmation by microscopy or
rapid diagnostic test (RDTs) for all patients with sus-
pected malaria before treatment is started [1,2]. Treat-
ment solely on the basis of clinical suspicion should be
considered only when a parasitological and or RDT diag-
nosis is not accessible [1-3]. Parasitological based diagno-
sis of malaria is currently of global public health priority
as use of more expensive and limited supply antimalarials
increases [4-6], malaria infection and disease become
rarer with increasing malaria control strategies [7] and
for good clinical practice [3].
In most malaria endemic countries of sub-Saharan
Africa, the current standard for laboratory confirmation
of a clinical malaria diagnosis is a peripheral blood film,
examined microscopically. However, microscopic based
diagnosis of malaria is labour-intensive requiring trained
staff and quality equipment attributes that are scarce in
resource-poor settings [8,9]. Thus, most clinicians often
rely on clinical signs and symptoms for diagnosis of
malaria, even when slide microscopy is available [10,11].
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any medium, provided the original work is properly cited.Besides, when anti-malarials were relatively cheap, pre-
sumptive treatment of all fever cases was deemed more
cost-effective [12].
Uganda piloted the histidine-rich protein II (HRP2)-
based RDT (Paracheck) and rolled it out as an instru-
ment of choice for parasite-based malaria diagnosis and
patient management in six districts in the first phase in
2008. Paracheck was distributed to parish-level and to
selected sub-county health centres (HCs) without
laboratory infrastructure. RDTs have been out of stock
for twelve months. Currently, there are 955 sub-county
and 2,008 parish-level HCs in 112 districts in the coun-
try. Depending on availability of RDTs, scaling up to
additional 22 districts is planned for January 2011.
Some data suggest that RDTs may not be very sensi-
tive especially in varying transmission intensities [13,14].
However, most evaluations of RDTs have used expert
microscopy as gold standard [15-17]. Since both micro-
scopy and RDTs have limitations in identifying malaria
infection [13,18,19], there is need to use a more accurate
gold standard (such as PCR) in assessing the accuracies
of these diagnostic tests. The aim of this study was to
compare the diagnostic accuracy of a histidine-based
RDT (Paracheck) to that of HC microscopy, expert
microscopy and presumptive diagnostic method in diag-
nosis of malaria in rural HCs of Uganda, with PCR as
gold standard.
Methods
Study setting
Data was collected from June to July 2007 in three ran-
domly selected sub-county level government HCs in
Bushenyi and three in Iganga districts of Uganda. Bush-
enyi is categorized as low and Iganga as high malaria
transmission intensity settings. The annual entomologi-
cal inoculation rates are not known, but are reported to
be <10 and >500 infective bites per person per year in
the neighboring districts of Kanungu and Tororo
respectively [20]. The detailed description of the study
sites has already been published [6].
A sub-county level HC laboratory is manned by one
laboratory assistant who has two years of pre-service
training. The laboratory personnel perform all investiga-
tions requested by the clinician. For malaria, at least one
out of ten slides is stored daily for quality control. The
district laboratory-focal person (who is also the in-
charge of the district hospital laboratory) performs quar-
terly technical support supervision to HC laboratories.
During supervision the microscope, stains, staining of
slides and reporting are checked. The supervisor per-
forms fresh films with the laboratory assistant. Where
necessary, an immediate feedback is given, but also
takes a percentage of the slides for further examination.
The external quality assurance is coordinated at the
national level. As contribution to improvement in the
delivery of services, the study provided HC laboratories
with new binocular microscopes, reagents and supplies.
Sample size estimation
Using a nomogram [21], estimated malaria prevalence of
63.5% [22], p-value set at 0.05, with estimated sensitivity
of Paracheck of 95% [23], a sample size of 150 in each
district was appropriate totalling 300 patients for the
two districts.
Participants and eligibility
All male and female outpatients attending study centres
with clinical suspicion of uncomplicated malaria based
on fever and or history of fever within the previous
48 hours were eligible for inclusion in the study. Lack of
consent and incomplete data constituted the exclusion
criteria.
Training of study team
The research team comprised of staff of the selected
HCs (three clinical officers, three laboratory assistants,
nine nurses) and three research assistants per district.
A one-week residential training workshop was con-
ducted in each district. Standard operating procedures
for: 1) finger prick for collection of blood, 2) thick/thin
blood smear preparation, 3) staining smears, 4) blood
smear reading, 5) preparation and reading of Paracheck,
and 6) collection of blood on filter paper for PCR were
used in training. All members were trained in theory
and practice during pilot testing of the patient case
report forms (CRFs). Data collection commenced after
inter-reader reliability for Paracheck reached a very
good agreement (kappa coefficient = 0.97).
Design and patient enrolment
This was a diagnostic clinical trial. The diagnosis of
malaria was made in the outpatient department by the
attending HC clinicians. Only those eligible were
informed about the study. Those who gave consent were
consecutively enrolled. Medical history, socio-economic
and demographic data were recorded on CRFs. Figure 1
shows the trial profile.
Description of laboratory procedures
Malaria microscopy
Blood for thick and thin smears, RDT and PCR were col-
lected from the same finger-prick. Duplicate thick and
thin smears were prepared on separate frosted slides bear-
ing the patient’s identification number. Standard staining
was made using the “Field’ss t a i n ” method. This method
provides a readable film within few minutes compared to
“Giemsa stain.” The Field’ss t a i nw a st h eo n l yr e - a g e n t
available in HCs and to which the laboratory assistants
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cation x1,000) under natural light (none of the study HCs
had electricity). Each film was graded as positive (asexual
malaria parasites seen) or negative (no malaria parasites
seen) based on the inspection of 200 fields of the thick
smear. The parasite density was estimated assuming 8,000
white blood cells/μl [24]. The thin smear was useful in
species identification. The laboratory assistants were
blinded of the RDT results. All slides were stored in
secured slide-boxes and read by an expert microscopist at
Mbarara Regional Referral/University Teaching Hospital
located in western Uganda. For quality control, all slides
were re-read by another expert microscopist at Makerere
University School of Public Health in Kampala. The expert
microscopist was blind to HC microscopy and RDT
results. The readings of the expert microscopist and that
of the quality control microscopist were discrepant in
seven slides. In these cases, the judgement of another
senior laboratory technician was final.
All HC laboratory personnel had ≥4 years of work
experience at the study HCs. The expert microscopist
was a senior laboratory technician with eight years of
work/research experience at Mbarara Regional Referral/
University teaching hospital. Quality control was per-
formed by senior laboratory personnel with over nine
years of work/research experience.
Paracheck Pf
The choice of Paracheck Pf device (Orchid Biomedical
Systems, Goa, India) was based on its stability [3], low
cost, reported high sensitivity (97%) and moderate speci-
ficity (88%) in controlled trials, ease of use [16] and it
was likely to be preferred by the Uganda Ministry of
Health. About 5μl of blood was drawn by the laboratory
assistant using a loop provided with the device. The test
preparation and interpretation was done following man-
ufacturer’s instructions. Each test was read by two
trained nurses. The nurses were not aware of the micro-
scopy results. The test was considered positive when the
antigen and control lines were visible in their respective
windows, negative when only the control band was visi-
ble and invalid when the control band was not visible.
Faint test lines were considered positive. The readings
were discrepant in two faint test lines, where the judge-
ment of a third trained nurse was final.
The PCR assay
The Plasmodium falciparum species-specific nested PCR
was preferred because this species contributes majority of
malaria morbidity in Uganda. Those infected with
P. falciparum are likely to suffer poor outcomes if they
are not appropriately managed. Finger-prick blood was
blotted on Whatman 3 MM filter paper, dried in dust
free area, wrapped inplastic sample bags and placed in a
zip-lock bag with silica gel to prevent DNA degradation.
The samples were sent to Makerere University-University
of California San Francisco Molecular Research Labora-
tory http://muucsf.org/index.html located in Mulago
National Referral Hospital in Kampala for analysis. DNA
was extracted from filter paper using the chelex method
Health centre microscopy
Paracheck Paracheck
         Expert    microscopy                                    Expert  microscopy
PCR                           PCR                                                        PCR
+ve,36 -ve,3 +ve,6 -ve,3 -ve,1     -ve,7        +ve,5  -ve,2 +ve,34 -ve,21 +ve,8  -ve,174 
Fnal sample, n=300
Positive (+ve), 56 Negative (-ve), 244 
+ve, 48 -ve, 8 +ve, 62 -ve, 182
+ve, 7 -ve, 55  -ve, 182 +ve, 39 -ve, 9 +ve, 1 -ve, 7
Enrolled, n=317 Excluded 
5 left before interview
4 women withdrew consent 
3 refused finger-prick 
5 non-falciparum mono-infection  
Figure 1 Trial profile.
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ciparum species-specific nested PCR of 18 S small sub-
unit ribosomal DNA was performed following a standard
protocol [26]. PCR products were stained by ethidium
bromide and resolved by gel electrophoresis on a 2.5%
agarose gel. DNA size standards were separated alongside
PCR products to allow sizing of species bands. Upon
completion of the gel electrophoresis, gels were placed in
a gel imaging cabinet and digitally photographed under
ultraviolet light. Gel images were printed and corre-
sponding sample lanes scored visually for the presence of
P. falciparum. Positive and negative controls were used
for each round of PCR. In addition, twenty two samples
were randomly selected plus eight samples that were
positive by PCR only (10% of the total) for re-analysis as
a quality control measure. Quality assurance is performed
by the University of California San Francisco, USA.
Patient management
The field microscopy results and that of Paracheck were
forwarded to the clinician to guide on the treatment
decision. All patients with positive test results (slide or
Paracheck) were immediately treated with artemether-
lumefantrine (the current first-line anti-malarial) on the
same day of visit. Patients with negative results received
further assessment and an appropriate treatment strategy
was given.
Statistical analysis
Data was double-entered and validated in EpiData ver-
sion 3.1 software (The EpiData Association, Odense,
Denmark) and analysed using Stata version 10 (Stata
Corp, Lakeway, College Station, Tx, USA). The sensitiv-
ity, specificity, PPV and NPV of HC microscopy, expert
microscopy, axillary temperature diagnosis and RDT
were determined with PCR as gold standard. A sub-
analysis with expert microscopy as gold standard was
performed to compare the results with that of PCR.
Sensitivity was calculated as the proportion of positive
test results obtained among samples containing malaria
parasites by PCR, specificity as the proportion of nega-
tive test results obtained among samples whose PCR
results were negative. PPVs and NPVs were calculated
as the proportion of true-positive results among all posi-
tively reacting samples and as the proportion of true
negative results among all negatively reacting samples,
respectively. Accuracy of each test was calculated overall
with 95% confidence interval (CI) and then adjusted for
age-groups and level of transmission intensity using a
stratified analysis. Because PCR was P. falciparum spe-
cies-specific, and yet Paracheck only detects P. falci-
parum, five non-falciparum mono-infections (three
Plasmodium malariae and two Plasmodium ovale)w e r e
excluded in the analysis.
Ethical approval
The study was approved by Makerere University School
of Public Health Institutional Review Board; and the
Uganda National Council for Science and Technology
(Ref: HS 209). Written informed consent was sought
from participants (or parents/legal guardians for minors)
at the time of interview. The study is registered with the
Clinicaltrials.gov (NCT00565071).
Results
Socio-demographic profile of subjects
Three hundred seventeen patients were enrolled from
June to July 2007. Five patients left before interview,
four female patients withdrew consent because they
wanted to consult their husbands, three feared the fin-
ger-prick and it was not possible to get blood specimens
while five had non-falciparum mono-infection. The final
sample was 300 patients. All were rural and majority
were peasants. Their mean age was 17.1 years (range
three months to 88 years). Those under five years of age
were 117 (39.1%) while 175 (58.5%) were below
14 years. Females constituted 191(63.7%) of the sample.
One hundred thirty four patients (44.7%) slept under
insecticide treated mosquit on e tan i g h tp r i o rt oe n r o l -
ment into the study (Table 1).
The mean duration of illness before reporting to study
HCs was 4.0 days [95%CI: 3.3-4.7] for children under-
five years and 5.9 days [95%CI: 4.5-7.4] for those ≥5
years. At least 170(56.6%) had used some medications
before reporting to study HCs. These included antima-
larials 58(34%), analgesics 125(73.5%) and antibiotics 43
(25.3%). Some patients used combinations of medicines.
Overall results of diagnostic techniques
Out of 300 patients, 88(29.3%) had fever (temperature
≥37.5°C) with a mean of 38.3°C. Fifty-six (18.7%) slides
were positive by HC microscopy and 47(15.7%) by expert
microscopy (Table 1). The geometric mean of asexual
parasitaemia was 111/μl. Paracheck detected 110 (36.7%)
positive cases and 89 (29.7%) by PCR. The PCR gave
positive results in eight patients who were negative with
microscopy and Paracheck. Out of 58 patients who had
used anti-malarials, the following tested positive: HC
microscopy 16 (27.6%), expert microscopy 13 (22.4%),
Paracheck 27 (46.6%) and PCR 26 (44.8%). Their geo-
metric mean of asexual parasitaemia was 96.4/μl.
Sensitivity and specificity of diagnostic techniques
Basing on PCR as gold standard (Table 2) the overall
sensitivity of presumptive diagnosis based on axillary
temperature, HC microscopy, expert microscopy and
Paracheck were: 39.3%, 47.2%, 46.1% and 91% respec-
tively. The corresponding specificity rates were: 74.9%,
93.4%, 97.2% and 86.3% respectively. With a sub-analysis
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sensitivity for presumptive diagnosis based on axillary
temperature, HC microscopy and Paracheck were:
42.6%, 85.1% and 97.9% respectively. The correspond-
ing specificity rates were: 73.1%, 93.7% and 74.7%
respectively.
In the low transmission setting, sensitivity of Para-
check was 75%. The sensitivity of presumptive diagnosis
based on axillary temperature, HC- and expert micro-
scopy was very low (25% for each). Unlike HC micro-
scopy 94.2% [95%CI: 88.9-97.5], the specificity of expert
microscopy 98.6% [95%CI: 94.9-99.8] was significantly
higher than that of Paracheck 90.6% [95%CI: 84.4-94.5],
p = 0.004.
In the high transmission setting, the sensitivity of
Paracheck was 93.5% [95%CI: 85.5-97.9] and signifi-
cantly higher than that of other diagnostic methods (p <
0.001 for each comparison). Its specificity (78.1%) was
significantly lower than that of HC microscopy 91.8%
[95%CI: 83-96.9] (p < 0.001) or expert microscopy 94.5%
[95%CI: 86.6-98.5] (p < 0.001), but similar to presump-
tive diagnosis based axillary temperature.
With regard to age, the sensitivity of Paracheck was
significantly higher than that of other techniques and
was excellent in children <5 years of age 97.7% [95%CI:
88-99.9] compared to those ≥5 years 83.7% [95%CI:
69.3-93.2]. The specificity of Paracheck in children <5
years was 79.5% [95%CI: 68.4-88.0] while it was 89.9%
[95%CI: 83.6-94.3] in those ≥5 years. The specificity
of HC microscopy 95.7% [95%CI: 90.8-98.4] in patients
≥5 years was not different from that of expert micro-
scopy 98.6% [95%CI: 94.9-99.8]. In addition, the specifi-
city of HC microscopy 89.0% [95%CI: 79.5-95.1] in
children <5 years was not statistically different from that
of expert microscopy 94.5% [95%CI: 86.6-98.5].
Positive and negative predictive values
Overall, only Paracheck had a NPV of >90%, while the
PPVs for all methods were <88%. In the low transmis-
sion setting, PPV was low for all diagnostic methods:
axillary temperature (7.5%), HC microscopy (27.3%),
expert microscopy (60%) and Paracheck (40.9%). In the
high transmission areas, the PPV for presumptive diag-
nosis (66.7%) was significantly lower than for other diag-
nostic methods. In addition, the PPV for expert
microscopy 90.5% [95%CI: 77.4-97.3], HC microscopy
86.7% [95%CI: 73.2-94.9] and Paracheck 81.8% [95%CI:
72.2-89.2] were statistically not different. The NPV for
Paracheck 97.7% [95%CI: 93.3-99.5] in low transmission
and 91.9% [95%CI: 82.3-97.3] in high transmission were
significantly higher than that of other methods. Only
Paracheck had a NPV >90% in both age-groups, being
Table 1 Selected characteristics of study participants
Selected variable Overall
n(%)
Low transmission
n(%)
High transmission
n(%)
p-value
(2-sided)
Proportion <5 years of age 117 (39.1) 52 (34.7) 65 (43.3) 0.124
Sleeps under mosquito net 134 (44.7) 78 (52) 56 (37.3) 0.015
Used anti-malarial prior to visiting study health centre 58 (34.1) 20 (20.6) 38 (52.1) 0.000
Axillary temperature ≥37.5°C 88 (29.3) 40 (26.7) 48 (32.0) 0.375
Health centre microscopy slide positive 56 (18.7) 11 (7.3) 45 (30.0) 0.000
Expert microscopy slide positive 47 (15.7) 5 (3.3) 42 (28.0) 0.000
Paracheck positive 110 (36.7) 22 (14.7) 88 (58.7) 0.000
PCR positive 89 (29.7) 12 (8.0) 77 (51.3) 0.000
PCR = Polymerase Chain Reaction
Table 2 Overall sensitivity, specificity, PPV and NPV of malaria diagnostic methods with PCR as gold standard
Diagnostic techniques Sensitivity
%(number/total)
[95%CI]
Specificity
%(number/total)
[95%CI]
PPV
%(number/total)
[95%CI]
NPV
%(number/total)
[95%CI]
Axillary temperature ≥37.5°C 39.3 (35/89)
[29.1-50.3]
74.9 (158/211)
[68.5-80.6]
39.8 (35/88)
[29.5-50.8]
74.5 (158/211)
[68.1-80.2]
Health centremicroscopy 47.2 (42/89)
[36.5-58.1]
93.4 (197/211)
[89.1-96.3]
75.0 (42/56)
[61.6-85.6]
80.7 (197/244)
[75.2-85.5]
Expert microscopy 46.1 (41/89)
[35.4-57.0]
97.2 (205/211)
[93.9-98.9]
87.2 (41/47)
[74.3-95.2]
81.0 (205/253)
[75.6-85.7]
Paracheck 91.0 (81/89)
[83.1-96.0]
86.3 (182/211)
[80.9-90.6]
73.6 (81/110)
[64.4-81.6]
95.8 (182/190)
[91.9-98.2]
PPV = Positive Predictive Value, NPV = Negative Predictive Value, 95%CI = 95% Confidence Interval
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[95%CI: 90.9-100] in those <5 years.
Discussion
The accuracy of clinical diagnosis routinely practiced at
rural HCs, health centre microscopy, expert microscopy
and Paracheck was compared in patients with uncompli-
cated malaria. The diagnostic accuracy of these methods
was measured against PCR as gold standard. Some stu-
dies have however reported on the accuracy of RDTs
using expert microscopy as gold standard [15-17]. For a
balanced comparison, a sub-analysis using expert micro-
scopy as gold standard was also performed.
If expert microscopy was the gold standard, the overall
sensitivity was consistently high. The sensitivity (97.9%),
specificity (74.7%) and NPV (99.5%) of Paracheck were
similar to that reported elsewhere [13,16,17,27]. When
PCR was used as gold standard, the sensitivity of Para-
check was 91%, specificity 86.4% and NPV 95.8%. The
sensitivity of expert microscopy (46.1%) was unaccepta-
bly low and similar to that of HC microscopy. A num-
ber of factors might have contributed to the low
sensitivity of microscopy including the inherent limita-
tions of microscopy [19], existence of low density infec-
tions and inappropriate use of anti-malarials [28]
resulting into low parasitaemia. The low sensitivity of
microscopy demonstrated here is an eye-opener to yet
another limitation not only to the use of malaria micro-
scopy as gold standard in research but also to interpre-
tation of results in routine patient care. Indeed this
finding substantiates the clinicians’ concerns that influ-
ence them specifically not to adhere to negative malaria
microscopy results [10,11]. Although low parasitaemic
patients are less at risk from severe clinical malaria epi-
sodes, they perpetuate parasite transmission, and are
still a public health concern [23]. For confident diagno-
sis of malaria in a routine outpatient practice, a sensitiv-
ity of >90% is critical [29] and this was only achieved by
Paracheck.
This study reports that 37% and 47% patients who
were negative by HC microscopy and expert microscopy
respectively were confirmed to have malaria by PCR.
These rates are slightly lower than that of another study
[12], which reported that 67% of patients, who had been
classified as negative by expert microscopy, were actually
positive by PCR. On the other hand, the rapid test iden-
tified positive cases in excess of the gold standard, likely
to be patients with persistently circulating antigen due
to prior use of anti-malarials. Microscopy techniques fell
short of the required critical level of sensitivity with the
potential consequences of missing infections in indivi-
duals who might even have had low immunity. Para-
check detected majority of malaria cases but also led to
treatment of a small percentage of patients without
malaria infection.
Eight patients were negative with microscopy and Para-
check, but positive with PCR. Even a repeat of the analy-
sis during quality control, the eight samples remained
positive. An earlier investigation [30] into the disappear-
ance of P. falciparum during treatment found that PCR
remained positive for a median of 144 hours. In another
study [31] PCR detected P. falciparum DNA from circu-
lating nonviable parasites after successful treatment.
However, HRP2-based RDTs remain positive after treat-
ment, and the HRP2 signal is of no value during the first
week of treatment [32]. Therefore, the eight patients with
positive PCR and negative HRP2-based RDT reported
here may represent P. falciparum with an HRP2 gene
deletion or reduced HRP2 expression [18], and such
patients never give a positive result with these tests [33].
The overall specificity of Paracheck was lower than
that of HC- and expert microscopy. This pattern was
also shown when data was adjusted by transmission
intensity and age-groups. The low specificity rates have
been attributed to persistent antigenaemia even after
successful treatment in some reports [18,23,27,34],
which is an inherent weakness in HRP2-based tests. In
the current study however, out of the 27 patients who
had prior use of antimalarials and were positive by Para-
check, only one was declared negative by PCR. It is
likely that although they had used anti-malarials, they
were still infected with malaria parasites.
Uganda has adopted RDT as a method for parasitolo-
gical diagnosis of malaria in addition to microscopy
[35]. RDTs are rolled out in lower level HCs where
microscopy services are not functional or not available.
The low sensitivity of HC microscopy reported here is
an indicator that the quality of malaria case diagnosis
greatly needs to be improved. This might involve
strengthening HCs through in-service training, being
equipped with adequate malaria diagnostic supplies,
improved technical laboratory support supervision, and
external quality assurance. Due to patient load (one
microscope serving 25,000 people at sub-county level
HC) and with laboratory investigations other than
malaria being requested, 20-30 malaria slides can be
examined satisfactorily per day. Therefore, many
patients are likely to be treated presumptively. If a
steady supply of RDTs is guaranteed, the distribution
should be extended to all lower level facilities. In addi-
tion, it is vital to routinely evaluate the performance of
RDTs as they are being rolled out in the country.
Although microscopy has limitations [19,36] plus the
low sensitivity reported here, it is useful in estimating
the level of parasitaemia in a blood film as well as for
detecting non-falciparum infections [35].
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has the ability to detect malaria parasites in patients with
low levels of parasitaemia. Infections with ≤5 parasites per
μl can be detected with 100% sensitivity and equal specifi-
city [26]. However, PCR also has limitations. PCR might
give false negative results if samples containing the para-
sites fail to amplify because the target sequence recognized
by oligonucleotide primers is absent or because it is pre-
sent but inaccessible. Absence of the target sequence may
be due to deletion/mutation of sequence homologous to
the primers, degradation of DNA during sample prepara-
tion and storage. Alternatively, if the correct target
sequence is present, amplification may fail due to inhibi-
tion of PCR by sample components. Also, target DNA
may not be accessible because of inadequate cellular lysis,
or the target sequence copy number may be too low for
amplicons to be detected under conditions used. False
positive PCR results might arise from carry over during
sample processing [37]. The urgency and importance of
obtaining results quickly for patients with suspected
malaria limits the usefulness of PCR in routine clinical
practice. Furthermore, in malaria endemic areas, limited
financial resources, persistent sub-clinical parasitaemia
and inadequate laboratory infrastructures in remote set-
tings preclude PCR as a diagnostic method. Nonetheless,
PCR remains a reference tool both clinically and in
research [38].
In estimation of the sample size with the aid of nomo-
gram [21], the prevalence of 63.5% was used. This study
reports the overall prevalence to be 36.7%. With all
other assumptions remaining constant, and using a
nomogram, the prevalence of 63.5% gives the same sam-
ple size as 36.7%. Therefore, the power of the study was
not affected.
Conclusion
High sensitivity of malaria diagnosis is important in all
settings, and essential for the most vulnerable popula-
tion groups in which malaria infection produces an
acute illness that can rapidly progress to death. The
HRP2-based test demonstrated a superior sensitivity
compared to microscopy and presumptive methods in
the diagnosis of uncomplicated malaria in remote health
facilities. Based on the current findings, the HRP2-baed
RDT may be more suitable for screening of malaria
infection in routine practice in primary health care
centres.
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